Work

1103P Real-world efficacy of relatlimab and nivolumab in advanced or resectable melanoma

Year: 2024

Type: article

Study design: Observational Study

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2024.08.1171

Authors: L. Karapetyan, S. Aflatooni, K. Ward, B. Withycombe, D. Kalos, Q. Mo, Z. Eroglu, A.S. Brohl, J. Markowitz, A. Tarhini, J. Messina, K.Y. Tsai, M. Perez, J.S. Zager, A. Sarnaik, R.I. Neves, V. Sondak, N.I. Khushalani

Institution: Moffitt Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Bristol-Myers Squibb, Array BioPharma

OpenAlex ID: W4402560762

FWCI: 0.312

Cites:

Cited by: 2

Related to: 10